307 related articles for article (PubMed ID: 20371140)
21. Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.
Chauhan SS; Gupta L; Mittal M; Vishwakarma P; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2010 Nov; 20(21):6191-4. PubMed ID: 20850302
[TBL] [Abstract][Full Text] [Related]
22. Leishmania donovani: effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate.
Valiathan R; Dubey ML; Mahajan RC; Malla N
Exp Parasitol; 2006 Oct; 114(2):103-8. PubMed ID: 16616137
[TBL] [Abstract][Full Text] [Related]
23. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents.
Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds.
Paloque L; Bouhlel A; Curti C; Dumètre A; Verhaeghe P; Azas N; Vanelle P
Eur J Med Chem; 2011 Jul; 46(7):2984-91. PubMed ID: 21555166
[TBL] [Abstract][Full Text] [Related]
27. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
Seifert K; Munday J; Syeda T; Croft SL
J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
Gatta F; Gradoni L; Lupardini E; Gramiccia M; Orsini S
Farmaco; 1991 Jan; 46(1):75-84. PubMed ID: 2054043
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of original amidoximes as antileishmanial agents.
Bouhlel A; Curti C; Dumètre A; Laget M; Crozet MD; Azas N; Vanelle P
Bioorg Med Chem; 2010 Oct; 18(20):7310-20. PubMed ID: 20833057
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiprotozoal activity of 4-arylcoumarins.
Pierson JT; Dumètre A; Hutter S; Delmas F; Laget M; Finet JP; Azas N; Combes S
Eur J Med Chem; 2010 Mar; 45(3):864-9. PubMed ID: 19914747
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
32. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.
Srinivas N; Palne S; Nishi ; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2009 Jan; 19(2):324-7. PubMed ID: 19091566
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
Seifert K; Escobar P; Croft SL
J Antimicrob Chemother; 2010 Mar; 65(3):508-11. PubMed ID: 20089542
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiprotozoal properties of pentamidine congeners bearing the benzofuran motif.
Bakunov SA; Bakunova SM; Bridges AS; Wenzler T; Barszcz T; Werbovetz KA; Brun R; Tidwell RR
J Med Chem; 2009 Sep; 52(18):5763-7. PubMed ID: 19757840
[TBL] [Abstract][Full Text] [Related]
35. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
[TBL] [Abstract][Full Text] [Related]
36. 1,3,5-Triazino Peptide Derivatives: Synthesis, Characterization, and Preliminary Antileishmanial Activity.
Khattab SN; Khalil HH; Bekhit AA; Abd El-Rahman MM; de la Torre BG; El-Faham A; Albericio F
ChemMedChem; 2018 Apr; 13(7):725-735. PubMed ID: 29388337
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents.
Bhandari K; Srinivas N; Marrapu VK; Verma A; Srivastava S; Gupta S
Bioorg Med Chem Lett; 2010 Jan; 20(1):291-3. PubMed ID: 19913413
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]